Alfresa Holdings Corporation

ALFRESA HOLDINGS CORPORATION deals with wholesaling, manufacturing, marketing and import/export of pharmaceuticals, diagnostic reagents, medical devices/equipment, etc., and operating dispensing pharmacies and conducting related businesses. The company annual revenue is 2,698.5 billion JPY, annual net income is 40.2 billion JPY, annual operating income is 47.6 billion JPY, total assets is 1,351.6 billion JPY, total liabilities is 876.7 billion JPY, total equity is 473.7 billion JPY as on 2020. The headquarters is in Japan.